Evidence map›Paper›PMID 39123496›Full record

ArticleCancers2024

Adipose Stem Cells and Their Interplay with Cancer Cells and Mitochondrial Reservoir: A New Promising Target.

Ayesha Rehman, Martina Marigliano, Martina Torsiello, Marcella La Noce, Gianpaolo Papaccio, Virginia Tirino, Vitale Del Vecchio, Federica Papaccio

Abstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ayesha RehmanDepartment of Experimental Medicine, Section of Human Histology and Embryology, University of Campania "L. Vanvitelli", Via L. Armanni 5, 80128 Naples, NA, Italy.ORCID 0009-0008-0395-3436
Martina MariglianoDepartment of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", Via S. Allende 43, 84081 Baronissi, SA, Italy.
Martina TorsielloDepartment of Experimental Medicine, Section of Human Histology and Embryology, University of Campania "L. Vanvitelli", Via L. Armanni 5, 80128 Naples, NA, Italy.
Marcella La NoceDepartment of Experimental Medicine, Section of Human Histology and Embryology, University of Campania "L. Vanvitelli", Via L. Armanni 5, 80128 Naples, NA, Italy.ORCID 0000-0002-8782-3821
Gianpaolo PapaccioDepartment of Experimental Medicine, Section of Human Histology and Embryology, University of Campania "L. Vanvitelli", Via L. Armanni 5, 80128 Naples, NA, Italy.ORCID 0000-0002-4014-5306
Virginia TirinoDepartment of Experimental Medicine, Section of Human Histology and Embryology, University of Campania "L. Vanvitelli", Via L. Armanni 5, 80128 Naples, NA, Italy.
Vitale Del VecchioDepartment of Experimental Medicine, Section of Human Histology and Embryology, University of Campania "L. Vanvitelli", Via L. Armanni 5, 80128 Naples, NA, Italy.ORCID 0000-0002-7323-4444
Federica PapaccioDepartment of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", Via S. Allende 43, 84081 Baronissi, SA, Italy.ORCID 0000-0002-0302-8696

Funding

Italian MIUR 2020ESS3F2
6 · The paper itself

Abstract

Adipose-derived stem cells (ASCs) significantly influence tumor progression within the tumor microenvironment (TME). This review examines the pro-tumorigenic roles of ASCs, focusing on paracrine signaling, direct cell-cell interactions, and immunomodulation. ASC-mediated mitochondrial transfer through tunneling nanotubes (TNTs) and gap junctions (GJs) plays a significant role in enhancing cancer cell survival and metabolism. Cancer cells with dysfunctional mitochondria acquire mitochondria from ASCs to meet their metabolic needs and thrive in the TME. Targeting mitochondrial transfer, modulating ASC function, and influencing metabolic pathways are potential therapeutic strategies. However, challenges like TME complexity, specificity, safety concerns, and resistance mechanisms must be addressed. Disrupting the ASC-cancer cell-mitochondria axis offers a promising approach to cancer therapy.

Indexed as

ASCscancer therapyCSCsdrug resistancemitochondriaTME

Identifiers

PMID39123496
PMCPMC11311803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.